酒精相关肝细胞癌常见遗传变异:病例对照全基因组关联研究
在2107例欧洲酒精性肝病患者中开展两阶段病例对照GWAS,发现WNT3A-WNT9A(rs708113)为酒精相关肝细胞癌易感位点,并在验证队列中重复验证;Meta分析显示WNT3A-WNT9A(OR 0.73)、TM6SF2(OR 1.77)、PNPLA3(OR 1.34)均达GWAS显著性。
要点
- 发现WNT3A-WNT9A(rs708113)为酒精相关肝细胞癌易感位点,Meta分析OR 0.73(95%CI 0.66-0.81)。
- TM6SF2(rs58542926)和PNPLA3(rs738409)与酒精相关肝细胞癌风险相关,Meta分析OR分别为1.77和1.34。
- WNT3A-WNT9A rs708113与肝纤维化无关,提示Wnt-β-catenin通路在癌变早期发挥作用。
核心结论
- WNT3A-WNT9A是酒精相关肝细胞癌的易感位点,提示Wnt-β-catenin通路在酒精相关肝细胞癌癌变中可能发挥早期作用。
研究设计与样本
- 两阶段病例对照全基因组关联研究,发现队列纳入2107例20-92岁欧洲酒精性肝病患者(1993年10月22日至2017年3月12日招募),验证队列纳入1933例29-92岁酒精性肝病患者(1995年7月21日至2019年5月2日招募)。
- 病例为经影像学或组织学诊断的酒精相关肝细胞癌患者,对照为无肝细胞癌的酒精性肝病患者;采用校正前十个主成分的加性逻辑回归模型评估遗传变异关联,并另做校正年龄、性别和肝纤维化的分析。
- 对两个病例对照队列进行Meta分析。
主要发现
- 发现队列包含775例病例和1332例对照,评估7 962 325个变异,鉴定出WNT3A-WNT9A(rs708113;p=1.11×10-8),并支持TM6SF2(rs58542926;p=6.02×10-10)、PNPLA3(rs738409;p=9.29×10-7)和HSD17B13(rs72613567;p=2.49×10-4)区域与酒精相关肝细胞癌风险的关联。
- 验证队列包含874例病例和1059例对照,重复验证了三个变异:WNT3A-WNT9A(rs708113;p=1.17×10-3)、TM6SF2(rs58542926;p=4.06×10-5)和PNPLA3(rs738409;p=1.17×10-4)。
- Meta分析中三个变异均达GWAS显著性:WNT3A-WNT9A(OR 0.73,95%CI 0.66-0.81;p=3.93×10-10)、TM6SF2(OR 1.77,95%CI 1.52-2.07;p=3.84×10-13)、PNPLA3(OR 1.34,95%CI 1.22-1.47;p=7.30×10-10);校正临床协变量后结果相似。
- 观察到风险等位基因对酒精相关肝细胞癌的累加效应;WNT3A-WNT9A rs708113与肝纤维化无关。
关键数值与推荐
- WNT3A-WNT9A rs708113与酒精相关肝细胞癌风险降低相关(OR 0.73,95%CI 0.66-0.81)。
- TM6SF2 rs58542926与酒精相关肝细胞癌风险升高相关(OR 1.77,95%CI 1.52-2.07)。
- PNPLA3 rs738409与酒精相关肝细胞癌风险升高相关(OR 1.34,95%CI 1.22-1.47)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatocellular carcinoma is a frequent consequence of alcohol-related liver disease, with variable incidence among heavy drinkers. We did a genome-wide association study (GWAS) to identify common genetic variants for alcohol-related hepatocellular carcinoma. METHODS: We conducted a two-stage case-control GWAS in a discovery cohort of 2107 unrelated European patients with alcohol-related liver disease aged 20-92 years recruited between Oct 22, 1993, and March 12, 2017. Cases were patients with alcohol-related hepatocellular carcinoma diagnosed by imaging or histology. Controls were patients with alcohol-related liver disease without hepatocellular carcinoma. We used an additive logistic regression model adjusted for the first ten principal components to assess genetic variants associated with alcohol-related hepatocellular carcinoma. We did another analysis with adjustment for age, sex, and liver fibrosis. New candidate associations (p<1 × 10-6) and variants previously associated with alcohol-related hepatocellular carcinoma were evaluated in a validation cohort of 1933 patients with alcohol-related liver disease aged 29-92 years recruited between July 21, 1995, and May 2, 2019. We did a meta-analysis of the two case-control cohorts. FINDINGS: The discovery cohort included 775 cases and 1332 controls. Of 7 962 325 variants assessed, we identified WNT3A-WNT9A (rs708113; p=1·11 × 10-8) and found support for previously reported regions associated with alcohol-related hepatocellular carcinoma risk at TM6SF2 (rs58542926; p=6·02 × 10-10), PNPLA3 (rs738409; p=9·29 × 10-7), and HSD17B13 (rs72613567; p=2·49 × 10-4). The validation cohort included 874 cases and 1059 controls and three variants were replicated: WNT3A-WNT9A (rs708113; p=1·17 × 10-3), TM6SF2 (rs58542926; p=4·06 × 10-5), and PNPLA3 (rs738409; p=1·17 × 10-4). All three variants reached GWAS significance in the meta-analysis: WNT3A-WNT9A (odds ratio 0·73, 95% CI 0·66-0·81; p=3·93 × 10-10), TM6SF2 (1·77, 1·52-2·07; p=3·84×10-13), PNPLA3 (1·34, 1·22-1·47; p=7·30 × 10-10). Adjustment for clinical covariates yielded similar results. We observed an additive effect of at-risk alleles on alcohol-related hepatocellular carcinoma. WNT3A-WNT9A rs708113 was not associated with liver fibrosis. INTERPRETATION: WNT3A-WNT9A is a susceptibility locus for alcohol-related hepatocellular carcinoma, suggesting an early role of the Wnt-β-catenin pathway in alcohol-related hepatocellular carcinoma carcinogenesis. FUNDING: Ligue Nationale contre le Cancer, Bpifrance, INSERM, AFEF, CARPEM, Labex OncoImmunology, and Agence Nationale de la Recherche.
引用
- Trépo E, Caruso S, Yang J, et al. Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study. Lancet Oncol. 2021. PMID: 34902334. doi:10.1016/S1470-2045(21)00603-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。